Story perspectives
Experts Confirm GLP-1 Medications Safe for Vision
8/23/2025
30 4
1 of 1
Story summary
- Dr. Andrew J. Barkmeier presented research at the 2025 ASRS meeting on GLP-1 medications and diabetic retinopathy, showing no increased risks in real-world use compared to the SUSTAIN-6 trial.
- Experts reassure patients about vision risks linked to GLP-1s, despite some studies suggesting potential connections to vision loss.
- The consensus is that the benefits of GLP-1 medications outweigh the risks for diabetes and weight management.
